# MycoWorks

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mycoworks

- Industry: Materials
- Headquarters: Emeryville, US
- Website: www.mycoworks.com
- Total disclosed funding: $201M
- Latest round: Series C (Jan 6, 2022)
- Investors on record: 19

## About

MycoWorks, Inc. specializes in innovative mycelium materials, offering sustainable alternatives to leather through their flagship product, Reishi™. Their focus aligns with luxury brands and environmentally conscious design.MycoWorks, Inc. is a company that produces sustainable mycelium-based materials, particularly known for their product, Reishi™. Founded in 2013 in Emeryville, US, the company has made significant advancements in its field. Notably, it raised USD 125.00 mn during its most recent funding round, Series C, on October 18, 2022, led by Prime Movers Lab and supported by investors including Data Collective and General Motors Ventures. The company has engaged in 7 funding deals to date. The founders of MycoWorks are Eddie Pavlu, Philip Ross, and Sophia Wang, while Matthew Scullin serves as the CEO.MycoWorks specializes in the production of innovative materials derived from mycelium, notably through their flagship product, Reishi™. This advanced material serves as a sustainable alternative to traditional leather, designed to meet the high standards of luxury brands while addressing environmental concerns associated with animal leather production. The Reishi™ product line includes applications in various industries such as fashion, furniture, and automotive, showcasing its versatility and aesthetic appeal. MycoWorks collaborates with a diverse clientele, including renowned design firms and automotive manufacturers, to integrate Reishi™ into high-performance products. Geographically, the company's offerings are marketed primarily in North America and Europe, with significant interest in design-centric markets like Scandinavia and major cities that prioritize sustainability in design.MycoWorks generates revenue through direct sales of its mycelium-based products, particularly the Reishi™ line, to both B2B and B2C clients. The transaction structure includes partnerships with retailers and wholesalers, allowing for broader distribution of their materials within the luxury segment. Clients interested in incorporating Reishi™ into their products engage with MycoWorks to establish tailored agreements that may involve bulk purchasing arrangements or exclusive collaborations. The company’s revenue model is enhanced by its appeal to high-end brands seeking innovative, sustainable materials for their collections, aligning product offerings with current market demands for eco-friendly solutions.MycoWorks plans to utilize the recent funding from the Series C round to advance its R&D efforts, focusing on developing more sustainable alternatives for designers. The company has strategies in place for upcoming product launches and intends to expand its presence in new geographic markets. Specific targets include increasing its influence in North American and European markets, particularly in regions that are design-centric and prioritize sustainability. MycoWorks aims to solidify its position in these markets by launching innovative products that cater to the growing demand for eco-friendly materials in various industries.

## Funding rounds

- Series C, Jan 6, 2022, $125M — Novo Holdings, SK, DCVC, Gaingels, Mirabaud Asset Management, Prime Movers Lab, Decarbonization Partners
- Series B, Oct 14, 2020, $45M — Valor Equity Partners, Novo Holdings, Gruss & Co, SOSV, W.T.T. Investment, DCVC, IndieBio, Gaingels, Wireframe Ventures, Humboldt Fund
- Series A, Feb 25, 2020, $17M — Novo Holdings, DCVC, Susa Ventures, Cthulhu Ventures, 8VC, AgFunder, Wireframe Ventures, Future Tech Lab
- Series A, May 8, 2019, $14M — SOSV, IndieBio
- Seed, Feb 26, 2016 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A, Series B
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed, Series A, Series B
- Novo Holdings — Series A, Series B, Series C
- DCVC (https://capitalatlas.ai/funds/dcvc) — Series A, Series B, Series C
- Susa Ventures (https://capitalatlas.ai/funds/susa-ventures) — Series A
- Cthulhu Ventures (https://capitalatlas.ai/funds/cthulhu-ventures) — Series A
- 8VC (https://capitalatlas.ai/funds/8vc) — Series A
- AgFunder (https://capitalatlas.ai/funds/agfunder) — Series A
- Wireframe Ventures (https://capitalatlas.ai/funds/wireframe-ventures) — Series A, Series B
- Future Tech Lab — Series A
- Valor Equity Partners (https://capitalatlas.ai/funds/valor-equity-partners) — Series B
- Gruss & Co — Series B
- W.T.T. Investment — Series B
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series B, Series C
- Humboldt Fund (https://capitalatlas.ai/funds/humboldt-fund) — Series B
- SK — Series C
- Mirabaud Asset Management (https://capitalatlas.ai/funds/mirabaud-asset-management) — Series C
- Prime Movers Lab (https://capitalatlas.ai/funds/prime-movers-lab) — Series C
- Decarbonization Partners (https://capitalatlas.ai/funds/decarbonization-partners) — Series C